West Paces Advisors’s Twist Bioscience TWST Stock Holding History

West Paces Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41K	Buy	+399	New	+$26K	0.01%	289
2025 Q2	–	Sell	-322	Closed	-$12.6K	–	532
2025 Q1	$12.6K	Hold	322	–	–	﹤0.01%	326
2024 Q4	$15K	Hold	322	–	–	﹤0.01%	319
2024 Q3	$14.5K	Hold	322	–	–	﹤0.01%	322
2024 Q2	$15.9K	Hold	322	–	–	﹤0.01%	310
2024 Q1	$11K	Hold	322	–	–	﹤0.01%	353
2023 Q4	$11.9K	Hold	322	–	–	﹤0.01%	346
2023 Q3	$6.52K	Hold	322	–	–	﹤0.01%	375
2023 Q2	$6.59K	Hold	322	–	–	﹤0.01%	399
2023 Q1	$4.86K	Hold	322	–	–	﹤0.01%	429
2022 Q4	$7.67K	Hold	322	–	–	﹤0.01%	374
2022 Q3	$11.3K	Hold	322	–	–	﹤0.01%	337
2022 Q2	$11.3K	Hold	322	–	–	﹤0.01%	359
2022 Q1	$15.9K	Hold	322	–	–	0.01%	332
2021 Q4	$24.9K	Hold	322	–	–	0.01%	290
2021 Q3	$34.4K	Hold	322	–	–	0.01%	241
2021 Q2	$42.9K	Hold	322	–	–	0.02%	218
2021 Q1	$39.9K	Buy	+322	New	+$48.9K	0.02%	210

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

West Paces Advisors's TWST Position: Q2 2026 in Review

West Paces Advisors opened a new position in Twist Bioscience (TWST) in Q2 2026: 399 shares worth $41K. The stake represents 0.01% of the portfolio and ranks #289 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in TWST as recently as Q1 2025.

West Paces Advisors first reported a position in TWST in Q1 2021 and has held it in 18 quarters since. The position peaked at $42.9K in Q2 2021. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

West Paces Advisors held 399 shares of Twist Bioscience worth $41K as of Q2 2026.
Twist Bioscience was a new West Paces Advisors position in Q2 2026.
Twist Bioscience made up 0.01% of West Paces Advisors's portfolio in Q2 2026, its #289 holding.
West Paces Advisors first reported a position in Twist Bioscience in Q1 2021 and has held it in 18 quarters since.
West Paces Advisors's Twist Bioscience position peaked at $42.9K in Q2 2021.
338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.